Archive for the ‘Research’ Category

Jett
Choquette

A Year for Scientific Innovation: How Biotechnology Fits into America’s Future

Friday, February 3rd, 2012

Photo credit: RACHEL DEVOR / THE EAGLE

Last week I had the opportunity to listen to two U.S. presidents discuss the future of America and the world – President Barak Obama in the 2012 State of the Union (via live-stream) and former President Bill Clinton at American University where he spoke about his latest work with the William J. Clinton Foundation (as a member of the audience).

While the purpose and overall messaging of both speeches were drastically different, one theme tied them together: America’s future depends on scientific innovation and, more importantly, investment in science. If the calls for action in both of these speeches materialize, this may be the year for biotechnology.

(more…)

Tags: , , , ,

 
Kelly
Barrett

BDI’s Social Communications & Healthcare 2011: Empowering employees to ‘play’ with social media

Tuesday, July 19th, 2011

Last Wednesday, I had the pleasure of attending the Business Development Institute’s Social Communications & Healthcare conference in New York City. It was the third year that BDI has put on the conference but one of the first times the event has included such robust case studies from industry leaders.

It is unfortunate that in pharma, we really don’t have many social media case studies to look at, yet. And this isn’t just because social media is new, because really, it’s not that new anymore (and what’s new today is old tomorrow). The problem lies more in the fact that so many companies and agencies are doing innovative stuff that they aren’t yet allowed to disclose. Here at Spectrum, a number of our progressive social media-related initiatives are highly sensitive and stay confidential. However, in the meantime, it’s inspiring to see all the ways people are finding to best socially communicate.

BDI Wrap Up from Zemoga on Vimeo.

(Pixels & Pills covered the event and they provide a ton of great video interviews that you should check out. And New Millenium Research & Consulting has photos up on their Facebook.)

(more…)

Tags: , , , , , , ,

 
Anthony
LaFauce

Being Part of the Story on the Screen: 3rd Annual Genetic Alliance Gene Screen

Friday, June 24th, 2011

Last night Spectrum had the privilege of hosting a Q&A session for the Genetic Alliance’s Gene Screen and I was honored to attend The Gene Screen, an annual review of films and shorts focused on health and genetics.  The session wasn’t long, around an hour and a half, but it was filled with the type of emotion normally reserved for big budget ‘tear jerkers.’

The list of films varied from personal stories like “Me and Antoine B.” and “Aiden’s Journey: Awareness and Hope” to more traditional Public Service Announcements like “No More Hand-Me-Downs: Research Designed for Children.” But the one thing they all had in common was their strength.

Strength isn’t something that often comes to mind when you think about the process of making a movie, but I was moved by the sheer force of will it took to make some of these films. Film production alone is a difficult, draining process that forces individuals to work long hours, editing and poring over meticulous tasks. Add to that the emotional burden of working on material as powerful and heartbreaking as the stories of these genetic disorders, and its truly remarkable the films were completed.

(more…)

Tags: , , , ,

 
Ricki
McCarroll

FDA beats out European Counterpart in Oncology Drug Approval

Thursday, June 16th, 2011

The FDA is proving to be a top contender in the international space in its efforts to fight the battle on the Big C, yes we’re talking cancer.

Source: Friends of Cancer Research Study

A new study released online today by Friends of Cancer Research in Health Affairs reports that the U.S. Food and Drug Administration (FDA) has a faster approval rate for oncology drugs than their European counterpart agency, the European Medicines Agency (EMA).

The study was held over a seven year period beginning 2003 through 2010. Authors Samantha A. Roberts, Jeff D. Allen, and Ellen V. Sigal investigated 35 drugs going through approval process in both markets and compiled their results in an eight-page report complete with graphics and pull quotes.

FDA v. EMA Stats

  • 35 drugs were investigated
  • FDA approved 32 oncology drugs while the EMA approved only 26
  • In addition, FDA’s approval for said drugs was over 31 percent more time efficient that the EMA

Statistically speaking, the approval ratio is less than one.

Finding the data

Authors of the study utilized public data bases on the FDA and EMA websites to conduct their research. Drugs used in the study are direct oncology treatments, drugs related to “supportive care” such as pain relievers and anti-nausea medications were omitted in their findings.

Check it Out

The Friends of Cancer Research study is currently available online and will be available in the July issue of Health Affairs.

What’s the spark under the FDA?

Tags: , , , , ,

 
Anthony
LaFauce

The Malaria Conversation on a Global Scale & What it Means for Communicators

Monday, May 23rd, 2011

With smart phones and Twitter at the ready, the first annual International Healthcare Social Media Summit kicked-off at 9:00 am EST on May 18th in Washington, D.C.

Spectrum’s own John Seng welcomed all attendees, virtual and physical, including GLOBALHealthPR partners from over seven countries and introduced the four panelists: Aurora PR‘s Neil Crump and Aaron Pond (UK) , PR Partners‘ Paola de la Barreda (Mexico) and Spectrum’s Anthony LaFauce.

Panelists presented data found in an 11 country, cross-cultural case study pertaining to the malaria pandemic and the evolving use of social media as an outreach resource. You can watch the event start to finish below.


(more…)

Tags: , , , ,

 
John
Seng

A Never-Smoker With Lung Cancer, And The Point Is…?

Tuesday, May 17th, 2011

The next time you hear that a friend of a friend was just diagnosed with lung cancer, you’re bound to wonder privately or out loud: Was he a smoker or not?

It’s only natural. We’re terrified of cancer, and especially, cancers such as lung cancer which are diagnosed usually in late stage, and oftentimes too late to really do much about it. So we all must hear what we need to hear that, yes, this person was or still is a smoker. Phew! We can again comfortably assign blame to some poor soul who should have known better or couldn’t muster the willpower to quit in time. And we think, I don’t smoke, so I’m innocent.

But increasingly we hear from multiple quarters that non-smokers and never-smokers also get lung cancer. In fact, approximately 10 percent of all lung cancer is diagnosed in persons who never smoked. That inconvenient reality surprises a lot of people. In other words, someone who didn’t have it coming to them just got really bad news, despite his or her good behavior, unlike those weak and irresponsible smokers. Some lung cancer advocates report this aberrance, in an attempt to add accurate perspective on the disease. Even more important, researchers are now investigating the differences between tumor types in never-smokers vs. smokers, and why women never-smokers bear a greater burden of disease.

But here’s a radical notion for you, one that I recently suggested to a group of lung cancer advocates gathered in Denver by the National Lung Cancer Partnership: Lung cancer is 100 percent a disease of innocents. I repeat, innocents.

I put forth the proposition that the lifelong female smoker diagnosed with lung cancer is no more “to blame” for her disease than another woman diagnosed with breast cancer. Here’s why. Tobacco use most often begins in our teen years. Raise your hand if you never did anything stupid as a 14-year old. The Army and Navy once distributed cigarettes free to hundreds of thousands of men to help them cope with battle stress. Tobacco companies handed out free samples on college campuses. I once found a copy of an ad for Lucky Strikes that depicts a doctor extolling the virtues of smoking. The best part is, the ad ran in a 1940s edition of The Journal of the American Medical Association. I framed the ad for my office.

(more…)

Tags: , , , , , , ,